
Would you like to receive update from CareSync Experts?
Summary, notice description and lot information
NHS England has completed the procurement process for the BGMA Joint Working Project, aimed at maximising the use of biosimilars in health services. This procurement, focusing on the health services industry, involved a direct procurement method via single tender action. The project addresses barriers to the uptake of biosimilars, with contracts awarded to the Biosimilar and Generics Manufacturers Association (BGMA).
The contract period commenced on 20th February 2025 and concluded on 31st March 2025. The procurement, valued at £20,000, took place at NHS England's headquarters in London, SE1 8UG, United Kingdom. This tender presents substantial opportunities for businesses specialising in health services, particularly those focused on innovative solutions for healthcare and pharmaceuticals.
Small and medium-sized enterprises (SMEs) involved in health services, medical supply chains, and pharmaceutical manufacturing stand to benefit significantly from participating in similar future projects aimed at overcoming industry barriers. Collaborations with major health organisations like NHS England offer robust growth prospects and enhance a company's portfolio within the public healthcare sector.
Notice type, method, and CPV codes
Financial information and value estimates
Contract duration information not available.
Publication, submission, and award timeline
Current status of tender, lots, awards, and contracts
Buyer organisation and contact details
Supplier who was awarded this contract
External resources and data downloads
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector.
Our expert team can help you prepare a winning bid. Get professional support from CareSync Experts.
Get in touch with our team at Care Sync Experts today for a consultation.
Email: hello@caresyncexperts.co.uk
Phone: 0333 577 0877
Contact Us